Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Hospira – Recall of dextrose 25% injection
April 21, 2017 – The FDA announced a hospital/user level recall of one lot of Hospira’s dextrose 25% injection due to the presence of human hair found within an internal sample syringe.
